Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001013762-25-002105
Filing Date
2025-03-25
Accepted
2025-03-25 15:44:38
Documents
1
Period of Report
2025-03-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3508
  Complete submission text file 0001013762-25-002105.txt   5150
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Issuer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONCONETIX, INC. 201 E. FIFTH STREET, SUITE 1900 CINCINNATI` OH 45202
Business Address
Oakley Andrew John (Reporting) CIK: 0002059152 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41294 | Film No.: 25768069